China SXT Pharmaceuticals, Inc.
Business
China SXT Pharmaceuticals, Inc. is an offshore holding company that conducts its business in China through subsidiaries and a variable interest entity, Taizhou Suxuantang, focusing on research, development, manufacturing, marketing and sales of traditional Chinese medicinal products (TCMP). It offers Advanced TCMP (including Directly‑Oral and After‑Soaking‑Oral formulations), Regular TCMP, and raw medicinal materials, with prior Fine TCMP offerings now discontinued. Its operations are organized through WFOE-provided technical and management services, R&D and GMP‑certified manufacturing facilities, quality control and patented processing technologies. The company primarily distributes TCMPs to hospitals, pharmaceutical distributors, wholesalers and chain pharmacies across multiple Chinese provinces (notably Jiangsu, Anhui, Jiangxi, Guangdong and Hubei) via regional sales offices and third‑party distributors.
Summary from filing dated 2025-07-31
Financials
Latest annual snapshot (FY2025, period end 2025-03-31). Full statement history unavailable for this entity.
| Revenue | — |
| Net income | $-3.30M |
| Total assets | $21.66M |
| Total liabilities | $6.22M |
| Stockholders' equity | $15.44M |
| Operating cash flow | $-2.35M |